Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67-Reference-Cited by-同舟云学术

Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67

Published:2013 Issue:5 Volume:80 Page:219-227
ISSN:1423-0291
Container-title:Pathobiology
language:en
Short-container-title:Pathobiology

Author:

Hassanein Mohamed,Huiart Laetitia,Bourdon Violaine,Rabayrol Laetitia,Geneix Jeanine,Nogues Catherine,Peyrat Jean Philippe,Gesta Paul,Meynard Paule,Dreyfus Helene,Petrot Dominique,Lidereau Rosette,Noguchi Tetsuro,Eisinger François,Extra Jean Marc,Viens Patrice,Jacquemier Jocelyne,Sobol Hagay

Publisher

S. Karger AG

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Reference49 articles.

1. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations

2. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1

3. Unusual case of Smith-Lemli-Opitz syndrome “type II”

4. The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain

5. Functions of the BRCA1 and BRCA2 genes

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporating immunohistochemical markers into screening methods for BRCA1-mutated breast cancer;Polish Journal of Pathology;2020

2. A CD146 FACS Protocol Enriches for Luminal Keratin 14/19 Double Positive Human Breast Progenitors;Scientific Reports;2019-10-16

3. Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer;BMC Cancer;2019-07-15

4. Comprehensive Proteomic Profiling–derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas;American Journal of Surgical Pathology;2018-09

5. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression;Breast Cancer Research;2018-07-11